Jupiter Neurosciences Deal History & Licensing Activity
Jupiter Neurosciences is a large biotech. Over the past three years, Jupiter Neurosciences has been involved in 1 licensing and acquisition transaction, with a primary focus on Small Molecules (2 deals).
Deals (12mo)
2
Active Trials
0
Top Modality
Small Molecules
Focus Area
Neurology
Jupiter Neurosciences Recent Deal Activity
Licensing, acquisition, and partnership transactions involving Jupiter Neurosciences in the past 12 months.
| Asset | Partner | Modality | Phase | Type | Date |
|---|---|---|---|---|---|
| MDMA program | PharmAla | Small Molecules | Unknown | collaboration | May 15, 2026 |
Jupiter Neurosciences Pipeline Focus
Therapeutic areas and modalities where Jupiter Neurosciences is most active based on deal history and clinical trial data.
Therapeutic Areas
Modalities
See How Your Asset Matches Jupiter Neurosciences's Portfolio
Use Solidus to benchmark upfront payments, milestones, and royalties for Neurology assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
Neurology Deal Benchmarks
Market sizing, deal terms, and competitive landscape for neurology
Small Molecules Benchmarks
Upfront, milestone, and royalty benchmarks for small molecules deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
Browse 850+ biotech and pharma company profiles with deal history and pipeline data
2026 Deal Benchmarks Report
Industry-wide analysis of deal terms, trends, and market dynamics
About Jupiter Neurosciences Licensing & Deal Activity
Jupiter Neurosciences is a large biotech company that has been actively engaged in licensing transactions across the biopharma landscape. With 1 deal over the past three years, Jupiter Neurosciences ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for Jupiter Neurosciences include Neurology (2 deals and trials). In terms of modality, Jupiter Neurosciences has shown particular interest in small molecules.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Jupiter Neurosciences and 850+ other biopharma companies. Use our Solidus to benchmark your asset against Jupiter Neurosciences's historical deal terms, or explore all company profiles to find the best partner match for your pipeline.